Persistent increase and improved survival of stage I lung cancer based on a large-scale real-world sample of 26,226 cases

Chengdi WANG; Jun SHAO; Lujia SONG; Pengwei REN; Dan LIU; Weimin LI.
Chinese Medical Journal ; (24): 1937-1948, 2023.
Artículo en Inglés | WPRIM | ID: wpr-980973

Documentos relacionados

  1. Persistent increase and improved survival of stage I lung cancer based on a large-scale real-world sample of 26,226 cases.
  2. EGFR mutation impacts recurrence in high-risk early-stage lung adenocarcinoma in the IASLC grading system.
  3. The prognostic impact of lung adenocarcinoma predominance classification relating to pathological factors in lobectomy, the Japanese Joint Committee of Lung Cancer Registry Database in 2010.
  4. Features of anaplastic lymphoma kinase rearrangement in early-stage lung cancer: Analysis of a nationwide Japanese database.
  5. Real-world applications of the new grading system in lung adenocarcinoma: A study of 907 patients focusing on revealing the relationship between pathologic grade and genetic status.
  6. Advanced Non-small Cell Lung Cancer: EGFR Mutation Analysis Using Pyrosequencing and the Fully Automated qPCR-Based Idylla<sup>TM</sup> System.
  7. [Application of the WHO Classification of Thoracic Tumors (2021) grading system in invasive pulmonary adenocarcinoma and its correlation with the targeted genes' variations].
  8. Mutation Profile of Resected <i>EGFR</i>-Mutated Lung Adenocarcinoma by Next-Generation Sequencing.
  9. A real-world study comparing perioperative chemotherapy and EGFR-tyrosine kinase inhibitors for treatment of resected stage III EGFR-mutant adenocarcinoma.
  10. High accuracy epidermal growth factor receptor mutation prediction via histopathological deep learning.